Make an appointment with a cancer specialist today.
Call us at 800-KARMANOS (800-527-6266)
Home / Physicians & Research / Professional Education / 2nd Annual Tumor and Microenvironment Retreat

2nd Annual Tumor and Microenvironment Retreat

Presented by the Tumor and Microenvironment Program at Karmanos Cancer Institute and Wayne State University School of Medicine.  

Hosted By

Shijie Sheng, PhD
Leader, Tumor and Microenvironment Program
Barbara Ann Karmanos Cancer Institute
Professor of Pathology and Oncology
WSU School of Medicine

Lawrence G. Lum, MD, DSc
Co-Leader, Tumor and Microenvironment Program
Scientific Director of BMT and Immunotherapy
Barbara Ann Karmanos Cancer Institute
Professor of Oncology, Imm&Micro
WSU School of Medicine

Date and Location

Wednesday, December 4, 2013 - 8:00 am - 4:30 pm

Margherio Conference Center
Wayne State Unviersity
1328 Scott Hall
Detroit, MI 

Breakfast and lunch will be provided at the Retreat.

Registration

This program is free for all participants. 

Program Agenda

8:00 – 8:30 a.m. 

Welcome & Opening Remarks from Wayne State University & Karmanos Cancer Institute

M. Roy Wilson, M.D., President, Wayne State University
Bonita Stanton, M.D., Vice Dean for Research, Wayne State University School of Medicine
Gerold Bepler, M.D., Ph.D., Director, Karmanos Cancer Institute, President & CEO, Karmanos Cancer Center, Wayne State University School of Medicine

   
SPOTLIGHT SESSION I
Chair: Gloria Heppner, PhD 
8:30 – 8:50 a.m. 

Functional role(s) of marrow adipocytes in bone metastatic disease
Izabela Podgorski, PhD
Assistant Professor, Department of Pharmacology
Wayne State University

8:50 – 9:10 a.m.
In vivo identification of adipocyte progenitors and an adipogenic niche for tissue remodeling
James Granneman, PhD
Professor, Department of Pathology
Center for Integrative Metabolic & Endocrine Research
Wayne State University
9:10 – 9:30 a.m. 

Mucus imprints intestinal dendritic cells with tolerogenic properties:  implications on the immune regulation in the tumor microenvironment
Kang Chen, PhD
Assistant Professor, Departments of Obstetrics & Gynecology and Immunology & Microbiology
Wayne State University

9:30 – 9:50 a.m.  Targeting solid and liquid tumors with bispecific antibody armed T cells
Lawrence Lum, MD, DSc
Professor, Departments of Oncology and Medicine and Immunology & Microbiology
Wayne State University
9:50 – 10:10 a.m.  Break  
   
SPOTLIGHT SESSION II
Chair: Wei-Zen Wei, PhD
 
10:10 a.m. – 10:30 a.m.  HPV in the etiology and outcomes of head and neck cancer
Ikuko Kato, PhD
Associate Professor, Department of Pathology
Wayne State University
10:30 – 10:50 a.m.  Unveiling the expression and function of discoidin domain receptors in breast cancer
Rafael Fridman, PhD
Professor, Department of Pathology
Wayne State University
10:50 – 11:10 a.m. 

Dissecting the intercellular signaling that controls breast development
Rodrigo Fernandez-Valdivia, PhD
Assistant Professor, Department of Pathology
Wayne State University

11:10 – 11:30 a.m.  Contemporary issues in uterine, serous, carcinoma
Rouba Ali-Fehmi, MD
Professor, Department of Pathology
Wayne State University
11:30 a.m. – 1:00 p.m.  Poster Session & Lunch  
KEYNOTE SESSION
Chair: Shijie Sheng, PhD
1:00 – 2:00 p.m.  Keynote Presentation 
Targeting the Tumor Microenvironment to Suppress Resistance to Cancer Therapeutics
Peter Nelson, MD
Professor of Oncology
Adjunct Professor of Genome Sciences and Pathology
University of Washington, Fred Hutchinson Cancer Research Center
2:00 – 2:15 p.m.  Break  
2:15 – 3:15 p.m.  Abstract Presentations  
   
SPOTLIGHT SESSION III
Chair: Lawrence Lum, MD, DSc 
 
3:15 – 3:35 p.m.  Think different: ubiquitin in normal physiology and disease
Sokol V. Todi, PhD
Assistant Professor, Departments of Pharmacology and Neurology
Wayne State University
3:35 – 3:55 p.m.  Chemokine and androgen signaling in prostate cancer progression
Sreenivasa R. Chinni, PhD
Associate Professor, Departments of Urology and Pathology
Wayne State University
3:55 – 4:15 p.m.  Overview of genitourinary oncology clinical trials
Ulka Vaishampayan, MD
Clinical Professor, Department of Oncology
Wayne State University
4:15 – 4:25 p.m.  Poster Award  
4:25 p.m. Closing Remarks and After Glow  

Abstract & Poster Submissions

Deadline for submission: Friday November 1, 2013. Abstracts will ONLY be accepted from Tumor and Microenvironment Program members.

Abstract Guidelines:
  • TITLE: the title must be brief and indicate clearly the nature of the investigation
  • AUTHOR NAMES: include name, academic title, department and university affiliation. List all authors in the order they should appear in the abstract byline. Designate a presenting author.
  • ABSTRACT BODY: The abstract title should be entered in small case, with only the first letter of the first word uppercased. Please avoid using ALL CAPS for abstract titles, quotation marks and bold fonts
  • Character limit of 3000 characters including spaces. Characters are counted for the abstract body.
  • Up to 3 references should be included
  • Submit your abstract online, click here
Poster Guidelines
  • Size Limitation: No larger than 46 inches and 96 inches wide
  • Required Elements: Title, authors, and abstract (as described above), graphic elements and references.
  • Please write your presentation concisely. Keep captions brief.
  • The poster should be self-explanatory so that you are free to supplement the information and discuss particular points raised by questions during the poster session.
  • Submit your poster information online, click here.
The poster session potentially provides a more intimate forum for informal discussion than the regular presentations, but this becomes more difficult if you are obliged to devote most of your time to merely explaining your poster to a succession of visitors. We will contact all poster submitters with drop off instructions prior to the Retreat. 

More Information

For more information contact Researchadmin@karmanos.org or 313-576-8734.

© 2014 Karmanos Cancer Institute Pencil
The Barbara Ann Karmanos Cancer Center is accredited by The Joint Commission.
If members of the public have any quality-of-care or safety concerns, they may notify The Joint Commission at 630-792-5800.